TNF and neoplasm: Because treatment with TNF is associated with strong systemic toxic side effects, the cytokine TNF-related apoptosis inducing ligand (TRAIL) has evolved as the most promising alterative for cancer therapy (TRAIL induces apoptosis in tumor cells while leaving non-transformed cells mostly unaffected) [8-10].